Investor QVT Financial LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by QVT Financial LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-14 13G/A ROIV / Roivant Sciences Ltd. 65,793,779 29,381,635
2025-08-14 13G/A TRML / Tourmaline Bio, Inc. 1,473,369 2,154,653
2025-05-15 13G TRML / Tourmaline Bio, Inc. 1,473,369
2025-02-28 13D/A ALLT / Allot Ltd. 2,857,225 3,555,793
2025-02-14 13G WHWK / Whitehawk Therapeutics, Inc. 2,313,702
2025-02-14 13G/A ROIV / Roivant Sciences Ltd. 66,719,779 65,793,779
2024-09-03 13D/A ALLT / Allot Ltd. 2,857,225
2024-03-07 13G/A ROIV / Roivant Sciences Ltd. 112,541,536 66,719,779
2024-02-14 13G/A ROIV / Roivant Sciences Ltd. 122,541,536 112,541,536
2023-05-18 13D/A MP / MP Materials Corp. 13,501,578 8,853,712
2023-05-09 13D/A MP / MP Materials Corp. 14,121,495 13,501,578
2023-02-14 13G/A ROIV / Roivant Sciences Ltd. 129,393,817 122,541,536
2022-09-08 13D/A MP / MP Materials Corp. 15,945,607 14,121,495
2022-06-09 13D/A MP / MP Materials Corp. 17,873,834 15,945,607
2022-03-11 13D/A MP / MP Materials Corp. 20,128,393 17,873,834
2022-02-14 13G/A GRIN / Victory Portfolios II - VictoryShares International Free Cash Flow Growth ETF 1,268,977 0
2022-02-14 13G ROIV / Roivant Sciences Ltd. 129,393,817
2021-09-20 13D/A MP / MP Materials Corp. 21,224,005 20,128,393
2021-03-31 13D/A MP / MP Materials Corp. 22,822,806 21,224,005
2021-02-16 13G/A GRIN / Victory Portfolios II - VictoryShares International Free Cash Flow Growth ETF 1,268,977
2020-12-23 13D/A MP / MP Materials Corp. 20,022,266 22,822,806
2020-11-27 13D MP / MP Materials Corp. 20,022,266
2020-02-14 13G/A AEHR / Aehr Test Systems, Inc. 1,847,215 0
2019-07-12 13D/A SIOX / Sio Gene Therapies Inc. 105,952,381 0
2019-07-12 13D/A MYOV / Myovant Sciences Ltd 40,765,599 0
2019-07-12 13D/A UROV / Urovant Sciences Ltd 0
2019-07-12 13D/A ABUS / Arbutus Biopharma Corporation 16,013,540 0
2019-06-14 13D MYOV / Myovant Sciences Ltd 38,341,357 40,765,599
2019-03-19 13D/A SIOX / Sio Gene Therapies Inc. 99,285,714 105,952,381
2019-02-14 13G/A HUNT / Hunter Maritime Acquisition Corp. 0
2019-02-14 13G/A MYOV / Myovant Sciences Ltd 37,231,342 38,341,357
2018-12-20 13D/A SIOX / Sio Gene Therapies Inc. 22,703,669 99,285,714
2018-10-10 13D UROV / Urovant Sciences Ltd 22,703,669
2018-10-10 13D SIOX / Sio Gene Therapies Inc. 89,285,714 22,703,669
2018-06-07 13D/A SIOX / Sio Gene Therapies Inc. 75,000,000 89,285,714
2018-02-14 13G/A PTN / Palatin Technologies, Inc. 14,102,011 5,096,095
2018-02-14 13G/A ATEX / Anterix Inc. 894,031 516,274
2018-02-14 13G/A AGEN / Agenus Inc. 4,455,874 3,201,263
2018-01-16 13D/A ABUS / Arbutus Biopharma Corporation 16,013,540 16,013,540
2017-10-17 13D/A ABUS / Arbutus Biopharma Corporation 16,013,540 16,013,540
2017-10-17 13D/A ABUS / Arbutus Biopharma Corporation 16,013,540
2017-02-21 13G/A ZXAIY / China Zenix Auto International Ltd - ADR 0
2017-02-10 13G MYOV / Myovant Sciences Ltd 37,231,342
2017-02-10 13G/A MYOV / Myovant Sciences Ltd 37,231,342 37,231,342
2017-02-09 13G/A AEHR / Aehr Test Systems, Inc. 1,410,548 1,847,215
2017-02-09 13G/A PTN / Palatin Technologies, Inc. 6,997,532 14,102,011
2017-02-09 13G/A ATEX / Anterix Inc. 864,301 894,031
2017-02-09 13G/A OCRX / Ocera Therapeutics, Inc. 1,058,787 1,032,957
2017-02-09 13G/A CYTR / LadRx Corp 5,850,399 0
2017-02-03 13G AGEN / Agenus Inc. 2,680,321 4,455,874
2016-11-28 13G HUNT / Hunter Maritime Acquisition Corp. 1,000,000
2016-11-28 13G HUNTU / Hunter Maritime Acquisition Corp. Unit 1,000,000
2016-08-22 13G SQNM / Sequenom, Inc. 6,320,963
2016-07-14 13D ABUS / Arbutus Biopharma Corporation 16,013,540 16,013,540
2016-07-13 13D SIOX / Sio Gene Therapies Inc. 75,000,000
2016-07-13 13D ABUS / Arbutus Biopharma Corporation 0 16,013,540
2016-02-17 13D/A ABUS / Arbutus Biopharma Corporation 16,013,540 0
2016-02-17 13G ATEX / Anterix Inc. 864,301
2016-02-16 13G/A MRTX / Mirati Therapeutics, Inc. 429,030
2016-02-16 13G/A CASC / Cascadian Therapeutics, Inc. 0 4,985,702
2016-02-11 13G/A PTN / Palatin Technologies, Inc. 6,997,532
2016-02-11 13G/A TVTX / Travere Therapeutics, Inc. 0 229,753
2016-02-11 13G/A ASMB / Assembly Biosciences, Inc. 535,000
2016-02-10 13G/A ARWR / Arrowhead Pharmaceuticals, Inc. 1,951,382
2016-02-10 13G/A OCRX / Ocera Therapeutics, Inc. 1,039,651 1,058,787
2016-02-10 13G/A AGEN / Agenus Inc. 2,680,321
2016-02-10 13G/A CYTR / LadRx Corp 5,850,399
2015-10-23 13G OCRX / Ocera Therapeutics, Inc. 1,039,651
2015-04-20 13G AEHR / Aehr Test Systems, Inc. 1,410,548
2015-03-16 13D ABUS / Arbutus Biopharma Corporation 16,013,540
2015-02-17 13G/A PTN / Palatin Technologies, Inc. 3,994,981
2015-02-17 13G/A TNGNQ / Tengion, Inc. 3,859,527
2015-02-17 13G/A TVTX / Travere Therapeutics, Inc. 2,053,019
2015-02-12 13G/A DHT / DHT Holdings, Inc. 2,461,538
2015-02-11 13G/A MRTX / Mirati Therapeutics, Inc. 685,077
2015-02-11 13G/A / VIVUS, Inc. 0
2015-02-11 13G/A ARWR / Arrowhead Pharmaceuticals, Inc. 3,779,482
2015-02-11 13G/A 76028H209 / Repros Therapeutics, Inc. 0
2015-02-11 13G/A US00448Q2012 / Achillion Pharmaceuticals, Inc. 515,583
2015-02-11 13G/A OCRX / Ocera Therapeutics, Inc. 738,298
2015-02-11 13G/A CYTR / LadRx Corp 5,143,564
2015-02-11 13G/A CASC / Cascadian Therapeutics, Inc. 5,044,484
2015-02-11 13G/A OREX / Orexigen Therapeutics, Inc. 0
2015-01-13 13G/A AGEN / Agenus Inc. 6,915,630
2015-01-02 13G ASMB / Assembly Biosciences, Inc. 535,000
2014-10-14 13G/A ARWR / Arrowhead Pharmaceuticals, Inc. 4,030,882
2014-09-16 13G/A DHT / DHT Holdings, Inc. 6,369,035
2014-09-02 13D PSMI / Peregrine Semiconductor Corp 3,253,988
2014-08-18 13G/A US00448Q2012 / Achillion Pharmaceuticals, Inc. 5,109,153
2014-05-14 13G OCRX / Ocera Therapeutics, Inc. 838,798
2014-03-21 13G CYTR / LadRx Corp 5,164,600
2014-03-10 13G/A ZXAIY / China Zenix Auto International Ltd - ADR 24,299,232
2014-02-14 13G/A US00448Q2012 / Achillion Pharmaceuticals, Inc. 10,816,953
2014-02-14 13G/A ITMN / 2,570,982
2014-02-14 13G AGEN / Agenus Inc. 9,259,260
2014-02-14 13G/A TNGNQ / Tengion, Inc. 1,295,563
2014-02-14 13G/A TPI / Tianyin Pharmaceutical Co., Inc. 937,500
2014-02-14 13G/A OREX / Orexigen Therapeutics, Inc. 10,731,747
2014-02-14 13G/A CASC / Cascadian Therapeutics, Inc. 5,702,299
2014-02-14 13G/A TVTX / Travere Therapeutics, Inc. 1,666,668
2014-02-14 13G/A ZXAIY / China Zenix Auto International Ltd - ADR 14,159,064
2014-02-14 13G MRTX / Mirati Therapeutics, Inc. 718,871
2014-02-14 13G/A ARWR / Arrowhead Pharmaceuticals, Inc. 2,047,782
2014-02-14 13G/A / VIVUS, Inc. 6,517,748
2014-02-14 13G/A 76028H209 / Repros Therapeutics, Inc. 2,023,695
2013-12-20 13G/A ZXAIY / China Zenix Auto International Ltd - ADR 13,838,808
2013-12-05 13G DHT / DHT Holdings, Inc. 2,105,000
2013-10-29 13G/A CASC / Cascadian Therapeutics, Inc. 4,179,040
2013-10-18 13G ARWR / Arrowhead Pharmaceuticals, Inc. 2,047,781
2013-09-23 13G CASC / Cascadian Therapeutics, Inc. 3,663,607
2013-08-26 13G TVTX / Travere Therapeutics, Inc. 1,675,212
2013-07-19 13G / VIVUS, Inc. 8,346,697
2013-07-08 13G TNGNQ / Tengion, Inc. 378,329
2013-05-20 13D/A / VIVUS, Inc. 8,346,697
2013-02-26 13G/A US00448Q2012 / Achillion Pharmaceuticals, Inc. 10,967,853
2013-02-14 13G/A CYTK / Cytokinetics, Incorporated 0
2013-02-14 13G/A ABG / Asbury Automotive Group, Inc. 1,381,287
2013-02-14 13G/A MDVN / Medivation, Inc.
2013-02-14 13G/A OCRX / Ocera Therapeutics, Inc.
2013-02-14 13G/A US00448Q2012 / Achillion Pharmaceuticals, Inc.
2013-02-14 13G/A ITMN /
2013-02-14 13G/A OREX / Orexigen Therapeutics, Inc.
2013-02-14 13G/A 032420101 / Anacor Pharmaceuticals, Inc.
2013-02-14 13G/A
2013-02-14 13G/A TPCG / Tpc Group Inc. 0
2013-02-14 13G/A STNG / Scorpio Tankers Inc.
2013-02-14 13G/A ZXAIY / China Zenix Auto International Ltd - ADR
2013-02-14 13G/A 76028H209 / Repros Therapeutics, Inc.
2012-11-15 13D / VIVUS, Inc. 8,346,697
2012-09-07 13G US00448Q2012 / Achillion Pharmaceuticals, Inc.
2012-07-10 13G PTN / Palatin Technologies, Inc.
2012-05-01 13G ZXAIY / China Zenix Auto International Ltd - ADR
2012-03-12 13G/A ITMN / 5,915,881
2012-03-12 13G/A OREX / Orexigen Therapeutics, Inc. 5,324,322
2012-03-12 13G/A / VIVUS, Inc. 8,166,144
2012-03-12 13G/A 76028H209 / Repros Therapeutics, Inc.
2012-02-14 13G/A ITMN /
2012-02-14 13G/A ZIOP / Alaunos Therapeutics Inc
2012-02-14 13G/A CYTK / Cytokinetics, Incorporated
2012-02-14 13G/A MDVN / Medivation, Inc.
2012-02-14 13G/A ABG / Asbury Automotive Group, Inc.
2012-02-14 13G/A NCTY / The9 Limited - Depositary Receipt (Common Stock)
2012-02-14 13G/A 032420101 / Anacor Pharmaceuticals, Inc.
2012-02-14 13G/A
2012-02-14 13G/A / VIVUS, Inc.